| Net Cash Provided by (Used in) Operating Activities |
$16,778,000 |
USD |
82% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$14,226,000 |
USD |
-72% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
12,447,522 |
shares |
0.18% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$2,552,000 |
USD |
94% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$50,637,000 |
USD |
20% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$5,384,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.04 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Interest Expense |
$15,559,000 |
USD |
195367% |
Q1 2025 |
Q1 2025 |